Pathologically or cytologically proven advanced, metastatic non-squamous non-small cell lung cancer, pleural malignant mesothelioma, bladder or urethral cancer, ovarian cancer, primary peritoneal cancer, thymoma and thymic cancer and uterine cervical cancer.

Measurable disease

Life expectancy of greater than 3 months.

Ability to take folic acid, vitamin B12, and dexamethasone according to protocol.

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

What this study is about